CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $231.67M, lower than 95% of all stocks globally
- FinancialsHigh earnings quality
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.44%
Annual Rate
CNY 0.10Paid annual
Payout Ratio
34.2%Sustainable
Last Ex-Dividend
Jul 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.56BCNY231.67M · vs all stocks (USD)
Trailing P/E
49.33xvs Medical Instruments & Supplies peers
Revenue (TTM)
219.42MCNY32.63M · vs all stocks (USD)
Profit Margin
13.66%vs Medical Instruments & Supplies peers
Beta
0.4330xvs all stocks
52-Week Change
-14.34%vs all stocks
Market Capitalization
1.56BCNY231.67M · vs all stocks (USD)
Enterprise Value
1.36BCNY202.95M · vs all stocks (USD)
Trailing P/E
49.33xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.88xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.86xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.22xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
37.53xvs Medical Instruments & Supplies peers
Gross Margin
57.84%vs Medical Instruments & Supplies peers
Profit Margin
13.66%vs Medical Instruments & Supplies peers
Operating Margin
13.20%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.68%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
5.85%vs Medical Instruments & Supplies peers
Revenue (TTM)
219.42MCNY32.63M · vs all stocks (USD)
Revenue per Share (TTM)
3.30CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-0.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
133.62MCNY19.87M · vs all stocks (USD)
EBITDA (TTM)
23.05MCNY3.43M · vs all stocks (USD)
Net Income (TTM)
29.97MCNY4.46M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
17.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
40.42MCNY6.01M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
75.12MCNY11.17M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.44%vs all stocks
Payout Ratio
34.22%vs Medical Instruments & Supplies peers
Revenue
219.67MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
86.86MCNYFY2025 · Dec 31, 2025Gross Profit
132.82MCNYFY2025 · Dec 31, 2025Operating Income
24.94MCNY3.71M · vs all stocks (USD)
Pre-tax Income
29.94MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.07MCNYFY2025 · Dec 31, 2025Net Income
28.87MCNYFY2025 · Dec 31, 2025EBIT
30.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
42.22MCNYFY2025 · Dec 31, 2025Research & Development
27.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
34.23MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
312.44KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
198.25KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
67.13MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
67.13MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
28.87MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
34.10MCNYFY2025 · Dec 31, 2025Free Cash Flow
30.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
47.70MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
28.87MCNYFY2025 · Dec 31, 2025Other Non-cash Items
913.93KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.04MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-10.00MCNYFY2025 · Dec 31, 2025Other Investing Activity
-23.83MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-37.02MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
29.80MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-30.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-10.36MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-10.56MCNYFY2025 · Dec 31, 2025Shares Outstanding
68.00MSharesUpdated Aug 21, 2026Float Shares
31.41MSharesUpdated Aug 21, 2026% Held by Insiders
57.14%vs all stocks
% Held by Institutions
3.16%vs all stocks
Total Cash (MRQ)
201.23MCNY29.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.99CNYUpdated Aug 21, 2026Total Debt (MRQ)
30.00MCNY4.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0575xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.58xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.76CNYUpdated Aug 21, 2026Total Assets
580.12MCNY86.27M · vs all stocks (USD)
Total Current Assets
381.84MCNYFY2025 · Dec 31, 2025Total Liabilities
65.77MCNYFY2025 · Dec 31, 2025Total Non-current Assets
198.28MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
8.67MCNYFY2025 · Dec 31, 2025Total Current Liabilities
57.10MCNYFY2025 · Dec 31, 2025Cash
42.40MCNYFY2025 · Dec 31, 2025Cash Equivalents
5.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
47.70MCNYFY2025 · Dec 31, 2025Other Short-term Investments
98.26MCNYFY2025 · Dec 31, 2025Accounts Receivable
5.51MCNYFY2025 · Dec 31, 2025Inventory
42.47MCNYFY2025 · Dec 31, 2025Accounts Payable
5.02MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
68.00MCNYFY2025 · Dec 31, 2025Retained Earnings
190.00MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
514.36MCNY76.49M · vs all stocks (USD)
Treasury Stock
10.03MCNYFY2025 · Dec 31, 202552-Week Low
17.63CNYUpdated Aug 21, 202652-Week High
29.78CNYUpdated Aug 21, 202652-Week Change
-14.34%vs all stocks
Beta
0.4330xvs all stocks
50-Day MA
20.93CNYUpdated Aug 21, 2026200-Day MA
25.37CNYUpdated Aug 21, 2026Avg 10-Day Volume
888.86KSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.08MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.4500CNYUpdated Aug 21, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $231.67M, lower than 95% of all stocks globallySignificant
Market cap (USD): 231,672,334.8Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Lantronix Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
HLE Glascoat Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sensortek Technology Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jantsa Jant Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CMK Corp
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guizhou Zhongyida Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Oiltek International Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hansol IONES Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hushan Autoparts Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Liaoning Kelong Fine Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Kingnet Network Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
Global Ship Lease Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
Hangzhou XZB Tech Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin